Curcumin-Er Prolonged Subcutaneous Delivery for the Treatment of Non-Small Cell Lung Cancer

Journal of Biomedical Nanotechnology - United States
doi 10.1166/jbn.2016.2207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Scientific Publishers

Related search

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Zein Nanoparticles as Nontoxic Delivery System for Maytansine in the Treatment of Non-Small Cell Lung Cancer

Drug Delivery
MedicinePharmaceutical Science
2019English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy